{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:49:21Z","timestamp":1768312161843,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Consejer\u00eda de Innovaci\u00f3n, Investigaci\u00f3n y Turismo del Gobierno de las Islas Baleares y del Fondo Social Europeo","award":["FPI\/2102\/2018"],"award-info":[{"award-number":["FPI\/2102\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s43440-020-00148-5","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T13:36:26Z","timestamp":1598880986000},"page":"288-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the antidepressant-like potential of the selective I2-imidazoline receptor ligand LSL 60101 in adult male rats"],"prefix":"10.1007","volume":"73","author":[{"given":"Elena","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas A.","family":"Garc\u00eda-Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-3775","authenticated-orcid":false,"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"issue":"1","key":"148_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1124\/pr.118.016311","volume":"72","author":"P Bousquet","year":"2020","unstructured":"Bousquet P, Hudson A, Garc\u00eda-Sevilla JA, Li JX. Imidazoline receptor system: the past, the present, and the future. Pharmacol Rev. 2020;72(1):50\u201379.","journal-title":"Pharmacol Rev"},{"key":"148_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1749-6632.1999.tb09388.x","volume":"881","author":"JA Garc\u00eda-Sevilla","year":"1999","unstructured":"Garc\u00eda-Sevilla JA, Escrib\u00e0 PV, Guim\u00f3n J. Imidazoline receptors and human brain disorders. Ann NY Acad Sci. 1999;881:392\u2013409.","journal-title":"Ann NY Acad Sci"},{"issue":"9","key":"148_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1001\/archpsyc.1996.01830090049008","volume":"53","author":"JA Garc\u00eda-Sevilla","year":"1996","unstructured":"Garc\u00eda-Sevilla JA, Escrib\u00e1 PV, Sastre M, Walzer C, Busquets X, Jaquet G, et al. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch Gen Psychiatr. 1996;53(9):803\u201310.","journal-title":"Arch Gen Psychiatr"},{"issue":"1","key":"148_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00001756-199612200-00034","volume":"8","author":"JA Garc\u00eda-Sevilla","year":"1996","unstructured":"Garc\u00eda-Sevilla JA, Escrib\u00e1 PV, Busquets X, Walzer C, Guim\u00f3n J. Platelet imidazoline receptors and regulatory G proteins in patients with major depression. NeuroReport. 1996;8(1):169\u201372.","journal-title":"NeuroReport"},{"issue":"7","key":"148_CR5","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1021\/acs.jmedchem.9b02080","volume":"63","author":"S Ab\u00e1s","year":"2020","unstructured":"Ab\u00e1s S, Rodr\u00edguez-Ar\u00e9valo S, Bag\u00e1n A, Gri\u00f1\u00e1n-Ferr\u00e9 C, Vasilopoulou F, Brocos-Mosquera I, et al. Bicyclic \u03b1-iminophosphonates as high affinity imidazoline I2 receptor ligands for Alzheimer\u2019s Disease. J Med Chem. 2020;63(7):3610\u201333.","journal-title":"J Med Chem"},{"key":"148_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1995.tb32397.x","volume":"763","author":"D Nutt","year":"1995","unstructured":"Nutt D, French N, Handley S, Hudson A, Husbands S, Jackson H, et al. Functional studies of specific imidazoline-2 receptor ligands. Ann NY Acad Sci. 1995;763:125\u201339.","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"148_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pnpbp.2011.11.005","volume":"37","author":"R Tonello","year":"2012","unstructured":"Tonello R, Villarinho JG, Sant'Anna GS, Tamiozzo L, Machado P, Trevisan G, et al. The potential antidepressant-like effect of imidazoline I2 ligand 2-BFI in mice. Prog Neuropsychopharmacol Biol Psychiatr. 2012;37(1):15\u2013211.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"issue":"2","key":"148_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00213-003-1392-3","volume":"167","author":"DP Finn","year":"2003","unstructured":"Finn DP, Mart\u00ed O, Harbuz MS, Vall\u00e8s A, Belda X, M\u00e1rquez C, et al. Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test. Psychopharmacology. 2003;167(2):195\u2013202.","journal-title":"Psychopharmacology"},{"issue":"5","key":"148_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/FBP.0000000000000454","volume":"30","author":"JN Siemian","year":"2019","unstructured":"Siemian JN, Shang L, Seaman RW Jr, Zhu Q, Zhang Y, Li JX. Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats. Behav Pharmacol. 2019;30(5):429\u201334.","journal-title":"Behav Pharmacol"},{"issue":"1","key":"148_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/026988110101500104","volume":"15","author":"MF O\u2019Neill","year":"2001","unstructured":"O\u2019Neill MF, Osborne DJ, Woodhouse SM, Conway MW. Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice. J Psychopharmacol. 2001;15(1):18\u201322.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"148_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0014-2999(95)00214-6","volume":"280","author":"R Alemany","year":"1995","unstructured":"Alemany R, Olmos G, Escrib\u00e1 PV, Menargues A, Obach R, Garc\u00eda-Sevilla JA. LSL 60101, a selective ligand for imidazolin I2 receptors, on glial fibrillary acidic protein concentration. Eur J Pharmacol. 1995;280(2):205\u201310.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"148_CR12","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/sj.bjp.0703485","volume":"130","author":"A Casanovas","year":"2000","unstructured":"Casanovas A, Olmos G, Ribera J, Boronat MA, Esquerda JE, Garc\u00eda-Sevilla JA. Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2-imidazoline receptor ligand LSL 60101. Br J Pharmacol. 2000;130(8):1767\u201376.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"148_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0269881112450785","volume":"27","author":"C Garau","year":"2013","unstructured":"Garau C, Miralles A, Garc\u00eda-Sevilla JA. Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain. J Psychopharmacol. 2013;27(2):123\u201334.","journal-title":"J Psychopharmacol"},{"issue":"15\u201316","key":"148_CR14","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00213-016-4342-6","volume":"233","author":"MJ Garc\u00eda-Fuster","year":"2016","unstructured":"Garc\u00eda-Fuster MJ, Garc\u00eda-Sevilla JA. Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD\/FADD ratio after chronic desipramine and fluoxetine administration. Psychopharmacology. 2016;233(15\u201316):2955\u201371.","journal-title":"Psychopharmacology"},{"key":"148_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neubiorev.2018.04.001","volume":"90","author":"CRAF Diniz","year":"2018","unstructured":"Diniz CRAF, Casarotto PC, Resstel L, Joca SRL. Beyond good and evil: a putative continuum-sorting hypothesis for the functional role of proBDNF\/BDNF-propeptide\/mBDNF in antidepressant treatment. Neurosci Biobehav Rev. 2018;90:70\u201383.","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"148_CR16","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.3390\/ijms19113650","volume":"19","author":"T Numakawa","year":"2018","unstructured":"Numakawa T, Odaka H, Adachi N. Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases. Int J Mol Sci. 2018;19(11):3650.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"148_CR17","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/npp.2011.119","volume":"36","author":"MJ Garc\u00eda-Fuster","year":"2011","unstructured":"Garc\u00eda-Fuster MJ, Flagel SB, Mahmood ST, Mayo LM, Thompson RC, Watson SJ, et al. Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD. Neuropsychopharmacology. 2011;36(11):2303\u201317.","journal-title":"Neuropsychopharmacology"},{"issue":"13","key":"148_CR18","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","volume":"172","author":"JC McGrath","year":"2015","unstructured":"McGrath JC, Lilley E. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol. 2015;172(13):3189\u201393.","journal-title":"Br J Pharmacol"},{"key":"148_CR19","unstructured":"Vasilopoulou F, Gui\u00f1\u00e1n-Ferr\u00e9 C, Rodr\u00edguez-Ar\u00e9valo S, Bag\u00e1n A, Garc\u00eda-Sevilla JA, Garc\u00eda-Fuster MJ et al (2019) I2-imidazoline ligand, LSL60101, improves cognition in the 5xFAD mouse model. In: 18th National Meeting of the Spanish Society of Neuroscience"},{"issue":"6","key":"148_CR20","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00213-020-05481-4","volume":"237","author":"C Bis-Humbert","year":"2020","unstructured":"Bis-Humbert C, Garc\u00eda-Cabrerizo R, Garc\u00eda-Fuster MJ. Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol. Psychopharmacology. 2020;237(6):1621\u201331.","journal-title":"Psychopharmacology"},{"issue":"1","key":"148_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/026988110001400106","volume":"14","author":"M Papp","year":"2000","unstructured":"Papp M, Wieronska J. Antidepressant-like activity of amisulpride in two animal models of depression. J Psychopharmacol. 2000;14(1):46\u201352.","journal-title":"J Psychopharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00148-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-020-00148-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00148-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:26:12Z","timestamp":1627946772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-020-00148-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["148"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00148-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}